Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.
about
Effective models for antimetastatic therapies.Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host.Targeting bromodomain and extraterminal proteins in breast cancer.MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target.
P2860
Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Immunocompetent mouse allograf ...... rget breast cancer metastasis.
@ast
Immunocompetent mouse allograf ...... rget breast cancer metastasis.
@en
type
label
Immunocompetent mouse allograf ...... rget breast cancer metastasis.
@ast
Immunocompetent mouse allograf ...... rget breast cancer metastasis.
@en
prefLabel
Immunocompetent mouse allograf ...... rget breast cancer metastasis.
@ast
Immunocompetent mouse allograf ...... rget breast cancer metastasis.
@en
P2093
P2860
P356
P1433
P1476
Immunocompetent mouse allograf ...... rget breast cancer metastasis.
@en
P2093
Diana C Haines
Howard H Yang
Huaitian Liu
Jeffrey E Green
Kent W Hunter
Lalage M Wakefield
Maxwell P Lee
Miriam R Anver
Peter H Watson
Philip Martin
P2860
P304
30621-30643
P356
10.18632/ONCOTARGET.15695
P407
P577
2017-02-25T00:00:00Z